Regenerative Medicine

Journal Title：Regenerative Medicine

Regenerative medicine replaces or regenerates human cells, tissue or organs, to restore or establish normal function*. Since 2006, Regenerative Medicine has been at the forefront of publishing the very best papers and reviews covering the entire regenerative medicine sector. The journal focusses on the entire spectrum of approaches to regenerative medicine, including small molecule drugs, biologics, biomaterials and tissue engineering, and cell and gene therapies – it’s all about regeneration and not a specific platform technology. The journal’s scope encompasses all aspects of the sector ranging from discovery research, through to clinical development, through to commercialization. Regenerative Medicine uniquely supports this important area of biomedical science and healthcare by providing a peer-reviewed journal totally committed to publishing the very best regenerative medicine research, clinical translation and commercialization.

Regenerative Medicine provides a specialist forum to address the important challenges and advances in regenerative medicine, delivering this essential information in concise, clear and attractive article formats – vital to a rapidly growing, multidisciplinary and increasingly time-constrained community.

Despite substantial developments in our knowledge and understanding of regeneration, the field is still in its infancy. However, progress is accelerating. The next few decades will see the discovery and development of transformative therapies for patients, and in some cases, even cures. Regenerative Medicine will continue to provide a critical overview of these advances as they progress, undergo clinical trials, and eventually become mainstream medicine.

再生医学替代或再生人体细胞、组织或器官，以恢复或建立正常功能*。自 2006 年以来，再生医学一直处于发表涵盖整个再生医学领域的最佳论文和评论的最前沿。该杂志专注于再生医学的所有方法，包括小分子药物、生物制剂、生物材料和组织工程，以及细胞和基因疗法——这完全是关于再生，而不是特定的平台技术。该杂志的范围涵盖了该领域的所有方面，从发现研究到临床开发，再到商业化。再生医学通过提供完全致力于发表最佳再生医学研究、临床翻译和商业化的同行评审期刊，为生物医学科学和医疗保健这一重要领域提供独特支持。

再生医学提供了一个专家论坛，以应对再生医学的重要挑战和进步，以简洁、清晰和有吸引力的文章格式提供这些重要信息——这对于快速发展、多学科和时间越来越紧迫的社区至关重要。

尽管我们对再生的知识和理解有了实质性的发展，但该领域仍处于起步阶段。然而，进展正在加速。在接下来的几十年里，我们将发现和开发针对患者的转化疗法，在某些情况下，甚至可以治愈。随着这些进展的进展、进行临床试验并最终成为主流医学，再生医学将继续提供对这些进展的批判性概述。

Regenerative Medicine创刊于2006年，由FUTURE MEDICINE LTD出版商出版，收稿方向涵盖医学 - 工程：生物医学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度较慢,6-12周，影响因子指数2.598，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。